Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Environ Toxicol ; 34(4): 530-538, 2019 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-30672636

RESUMEN

OBJECTIVES: Exposure to airborne particle (PM2.5 ) is a risk factor for intracranial atherosclerosis (ICA). Because of the established role of systemic inflammation and oxidative stress by PM2.5 , we determined whether these processes account for PM2.5 -mediated ICA, and also whether omega-3 fatty acid (O3FA) dietary supplementation could attenuate them. METHODS: Adult Sprague-Dawley rats were exposed to filtered air (FA) or PM2.5 and fed either a normal chow diet (NCD) or a high-cholesterol diet (HCD), administered with or without O3FA (5 mg/kg/day by gavage) for 12 weeks. The lumen and thickness of the middle cerebral artery (MCA) were assessed. Serum tumor necrosis factor alpha (TNF-α), interleukin 6 (IL-6), interleukin-1ß (IL-1ß), and interferon gamma (IFN-γ) were detected by ELISA. Reactive oxygen species (ROS), malondialdehyde (MDA), superoxide dismutase (SOD) activity, nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX) activity, mRNA levels of Nrf2, HO-1, NQO-1, and protein level of NOX subunit gp91 were quantified to determine the oxidative profile of brain vessels. RESULTS: PM2.5 increased (P < .05) ICA, especially in the HCD group; elevated serum TNF-α, IL-6, IL-1ß, and IFN-γ; increased cerebrovascular ROS, MDA, NOX activity, and gp91 protein levels; and decreased cerebrovascular SOD activity. Nrf2, HO-1, and NQO-1 mRNA levels were upregulated (P < .05) by PM2.5 exposure, especially in the HCD group. O3FA attenuated (P < .05) PM2.5 -induced systemic inflammation, vascular oxidative injury, and ICA. CONCLUSIONS: PM2.5 exposure induced systemic inflammation, cerebrovascular oxidative injury, and ICA in rats with HCD. O3FA prevented ICA development, and may therefore exert a protective effect against the atherogenic potential of PM2.5 .


Asunto(s)
Contaminantes Atmosféricos/toxicidad , Arteriosclerosis Intracraneal/inducido químicamente , Arteria Cerebral Media/efectos de los fármacos , Estrés Oxidativo/efectos de los fármacos , Material Particulado/toxicidad , Animales , Modelos Animales de Enfermedad , Inflamación , Arteriosclerosis Intracraneal/inmunología , Arteriosclerosis Intracraneal/patología , Masculino , Arteria Cerebral Media/inmunología , Arteria Cerebral Media/patología , Tamaño de la Partícula , Ratas , Ratas Sprague-Dawley , Especies Reactivas de Oxígeno/metabolismo
2.
Int J Mol Sci ; 15(11): 20913-26, 2014 Nov 13.
Artículo en Inglés | MEDLINE | ID: mdl-25402649

RESUMEN

Inflammation and oxidative stress play an important part in the pathogenesis of focal cerebral ischemia/reperfusion (I/R) injury, resulting in neuronal death. The signaling pathways involved and the underlying mechanisms of these events are not fully understood. Chrysin, which is a naturally occurring flavonoid, exhibits various biological activities. In this study, we investigated the neuroprotective properties of chrysin in a mouse model of middle cerebral artery occlusion (MCAO). To this end, male C57/BL6 mice were pretreated with chrysin once a day for seven days and were then subjected to 1 h of middle cerebral artery occlusion followed by reperfusion for 24 h. Our data show that chrysin successfully decreased neurological deficit scores and infarct volumes, compared with the vehicle group. The increases in glial cell numbers and proinflammatory cytokine secretion usually caused by ischemia/reperfusion were significantly ameliorated by chrysin pretreatment. Moreover, chrysin also inhibited the MCAO-induced up-regulation of nuclear factor-kappa B (NF-κB), cyclooxygenase-2 (COX-2), and inducible nitric oxide synthase (iNOS), compared with the vehicle. These results suggest that chrysin could be a potential prophylactic agent for cerebral ischemia/reperfusion (I/R) injury mediated by its anti-inflammatory and anti-oxidative effects.


Asunto(s)
Antiinflamatorios/uso terapéutico , Isquemia Encefálica/prevención & control , Flavonoides/uso terapéutico , Infarto de la Arteria Cerebral Media/tratamiento farmacológico , Inflamación/tratamiento farmacológico , Fármacos Neuroprotectores/uso terapéutico , Estrés Oxidativo/efectos de los fármacos , Animales , Antioxidantes/uso terapéutico , Isquemia Encefálica/inmunología , Isquemia Encefálica/patología , Citocinas/análisis , Citocinas/inmunología , Infarto de la Arteria Cerebral Media/inmunología , Infarto de la Arteria Cerebral Media/metabolismo , Infarto de la Arteria Cerebral Media/patología , Inflamación/inmunología , Inflamación/metabolismo , Inflamación/patología , Masculino , Ratones Endogámicos C57BL , Arteria Cerebral Media/efectos de los fármacos , Arteria Cerebral Media/inmunología , Arteria Cerebral Media/metabolismo , Arteria Cerebral Media/patología , Daño por Reperfusión/tratamiento farmacológico , Daño por Reperfusión/inmunología , Daño por Reperfusión/metabolismo , Daño por Reperfusión/patología
3.
Neurology ; 80(1): 62-8, 2013 Jan 01.
Artículo en Inglés | MEDLINE | ID: mdl-23243076

RESUMEN

OBJECTIVE: Pathologic changes in varicella-zoster virus (VZV)-infected arteries include inflammation, thickened intima, and paucity of smooth muscle cells. Since no criteria have been established for early vs late VZV vasculopathy, we examined inflammatory cells and their distribution in 6 normal arteries, and 2 VZV-infected arteries 3 days after onset of disease (early) and 10 months after protracted neurologic disease (late). METHODS: VZV-infected temporal artery obtained 3 days after onset of ischemic optic neuropathy from an 80-year-old man, VZV-infected middle cerebral artery (MCA) obtained 10 months after protracted disease from a 73-year-old man, and 5 MCAs and 1 temporal artery from normal subjects, age 22-60 years, were examined histologically and immunohistochemically using antibodies against VZV and inflammatory cell subsets. RESULTS: In both early and late VZV vasculopathy, T cells, activated macrophages, and rare B cells were found in adventitia and intima. In adventitia of early VZV vasculopathy, neutrophils and VZV antigen were abundant and a thickened intima was associated with inflammatory cells in vaso vasorum vessels. In media of late VZV vasculopathy, viral antigen, but not leukocytes, was found. VZV was not seen in inflammatory cells. Inflammatory cells were absent in control arteries. CONCLUSIONS: Both VZV and neutrophils exclusively in adventitia in early VZV vasculopathy indicate that disease begins there. Late VZV vasculopathy is distinguished by viral antigen without inflammation in media, revealing a human virus in an immunoprivileged arterial media. Association of thickened intima and inflammation in vaso vasorum vessels in early VZV vasculopathy support the role of virus-induced inflammation in vessel wall remodeling.


Asunto(s)
Herpesvirus Humano 3/inmunología , Arteria Cerebral Media/inmunología , Arterias Temporales/inmunología , Enfermedades Vasculares/inmunología , Virosis/inmunología , Adulto , Adventicia/inmunología , Anciano , Anciano de 80 o más Años , Linfocitos B/inmunología , Estudios de Casos y Controles , Femenino , Humanos , Inflamación/inmunología , Inflamación/patología , Inflamación/virología , Macrófagos/inmunología , Masculino , Persona de Mediana Edad , Arteria Cerebral Media/patología , Arteria Cerebral Media/virología , Neutrófilos/inmunología , Linfocitos T/inmunología , Arterias Temporales/patología , Arterias Temporales/virología , Túnica Íntima/inmunología , Túnica Íntima/patología , Enfermedades Vasculares/patología , Enfermedades Vasculares/virología , Virosis/patología , Virosis/virología
4.
J Neuroimmunol ; 232(1-2): 94-100, 2011 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-21059474

RESUMEN

BACKGROUND: The etiology of delayed cerebral vasospasm (DCV) after aneurysmal subarachnoid hemorrhage (SAH) has remained elusive. Growing evidence supports a role for inflammation in the pathogenesis of DCV. We showed that CSF neutrophils predict which patients will develop DCV. METHODS: We evaluated a murine model of SAH to test the hypothesis that myeloid cells are required for the cerebral damage associated with DCV. RESULTS: SAH was associated with decreased middle cerebral artery caliber on day 1 which normalized at day 3 and recurred at day 6. In addition, behavioral testing with a Barnes maze showed executive dysfunction that progressively worsened after the seventh day post hemorrhage. To test the role of innate immune responses, we administrated a myeloid cell-depleting monoclonal antibody against Ly6G/C prior to experimental SAH. Myeloid cell depletion ameliorated angiographic vasospasm measured by MCA vessel caliber and normalized behavioral testing. CONCLUSION: Our findings support the role of Ly6G/C(+) cells in the development of DCV after SAH and suggest that immune modulation of neutrophils or other Ly6G/C(+) cells may be a strategy for the prevention of DCV.


Asunto(s)
Inflamación/complicaciones , Inflamación/inmunología , Neutrófilos/inmunología , Hemorragia Subaracnoidea/complicaciones , Hemorragia Subaracnoidea/inmunología , Vasoespasmo Intracraneal/inmunología , Animales , Antígenos Ly/inmunología , Antígenos Ly/metabolismo , Separación Celular , Modelos Animales de Enfermedad , Citometría de Flujo , Inmunohistoquímica , Masculino , Aprendizaje por Laberinto , Ratones , Ratones Endogámicos C57BL , Arteria Cerebral Media/inmunología , Arteria Cerebral Media/patología , Células Mieloides/inmunología , Células Mieloides/metabolismo , Neutrófilos/metabolismo , Hemorragia Subaracnoidea/patología , Vasoespasmo Intracraneal/patología
5.
ScientificWorldJournal ; 1: 168-80, 2001 May 01.
Artículo en Inglés | MEDLINE | ID: mdl-12805660

RESUMEN

Amylin and adrenomedullin are two peptides structurally related to calcitonin gene-related peptide (CGRP). We studied the occurrence of amylin in trigeminal ganglia and cerebral blood vessels of the cat with immunocytochemistry and evaluated the role of amylin and adrenomedullin in the cerebral circulation by in vitro and in vivo pharmacology. Immunocytochemistry revealed that numerous nerve cell bodies in the trigeminal ganglion contained CGRP immunoreactivity (-ir); some of these also expressed amylin-ir but none adrenomedullin-ir. There were numerous nerve fibres surrounding cerebral blood vessels that contained CGRP-ir. Occasional fibres contained amylin-ir while we observed no adrenomedullin-ir in the vessel walls. With RT-PCR and Real-Time-PCR we revealed the presence of mRNA for calcitonin receptor-like receptor (CLRL) and receptor-activity-modifying proteins (RAMPs) in cat cerebral arteries. In vitro studies revealed that amylin, adrenomedullin, and CGRP relaxed ring segments of the cat middle cerebral artery. CGRP and amylin caused concentration-dependent relaxations at low concentrations of PGF 2alpha-precontracted segment (with or without endothelium) whereas only at high concentration did adrenomedullin cause relaxation. CGRP8-37 blocked the CGRP and amylin induced relaxations in a parallel fashion. In vivo studies of amylin, adrenomedullin, and CGRP showed a brisk reproducible increase in local cerebral blood flow as examined using laser Doppler flowmetry applied to the cerebral cortex of the alpha-chloralose-anesthetized cat. The responses to amylin and CGRP were blocked by CGRP8-37. The studies suggest that there is a functional sub-set of amylin-containing trigeminal neurons which probably act via CGRP receptors.


Asunto(s)
Amiloide/farmacología , Circulación Cerebrovascular/efectos de los fármacos , Arteria Cerebral Media/efectos de los fármacos , Adrenomedulina , Amiloide/administración & dosificación , Amiloide/inmunología , Amiloide/metabolismo , Animales , Péptido Relacionado con Gen de Calcitonina/inmunología , Péptido Relacionado con Gen de Calcitonina/metabolismo , Proteína Similar al Receptor de Calcitonina , Gatos , Relación Dosis-Respuesta a Droga , Femenino , Atrios Cardíacos/química , Humanos , Inmunohistoquímica/métodos , Técnicas In Vitro , Inyecciones Intraventriculares , Péptidos y Proteínas de Señalización Intracelular , Polipéptido Amiloide de los Islotes Pancreáticos , Masculino , Proteínas de la Membrana/biosíntesis , Arteria Cerebral Media/química , Arteria Cerebral Media/inmunología , Arteria Cerebral Media/inervación , Péptidos/administración & dosificación , Péptidos/inmunología , Péptidos/metabolismo , Péptidos/farmacología , Proteínas Modificadoras de la Actividad de Receptores , Receptores de Calcitonina/biosíntesis , Receptores de Calcitonina/inmunología , Receptores de Calcitonina/metabolismo , Ganglio del Trigémino/química , Ganglio del Trigémino/efectos de los fármacos , Vasodilatadores/farmacocinética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA